TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Diarrhea toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants that obtain HIV testing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of acute complications
Endpoint domain: Adverse events/effects
Primary endpoint: Severe AGVHD-free, severe CGVHD-free, relapse-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of Patients Persistent on Ofatumumab and Self-injectable DMTs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to Resuscitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Illness Intrusiveness Ratings Scale score (IIRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Hemoglobin A1c concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effectiveness: VTE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Effectiveness: Stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Serious Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Higher Rates of Employment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Higher Number of Hours Worked
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Increased Wages Earned
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improved Job Related Social Skills
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: PIVC Length of Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Infiltration
Endpoint domain: Adverse events/effects
Primary endpoint: Extravasation
Endpoint domain: Adverse events/effects
Primary endpoint: Occlusion
Endpoint domain: Adverse events/effects
Primary endpoint: Folding
Endpoint domain: Adverse events/effects
Primary endpoint: Dislocation
Endpoint domain: Adverse events/effects
Primary endpoint: World Health Organization quality of life instrument WHOQOL-BREF
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Biodex Gait Trainer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in the Fasting Blood Glucose (mg/dl) at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in the Insulin (uU/mL) at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in the BMI (kg/m2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTSIB test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virtual patient exam scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: temporomandibular joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of clinical features outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant prostate cancer (csPCa) detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Upper cross syndrome angles assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Belief Model Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Curve (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in WHYMPI score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Efficacy of neoadjuvant SBRT combined with PD-1 monoclonal antibody and chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete resolution of the wart(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Insulin-stimulated non-oxidative plasma glucose disposal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Vaccine completion rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Induction of clinical response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in fasting blood LDL-cholesterol level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Completed Referrals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Oral Health Attitude
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Oral Health Behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: IOP Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six-Minute Walk Distance at baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six-Minute Walk Distance 6-month change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-brain entrainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feedback-related negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ambulatory Drinking
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Longitudinal Drinking Problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Area Under the Concentration-Time Curve from Time 0 to Infinity (AUC0-Inf) of plasma MK-1084
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of plasma MK-1084
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Reach Maximum Concentration (Tmax) of plasma MK-1084
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Sadness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postpartum Self-Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mother-Infant Contact
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Incidence of human immunodeficiency virus (HIV)
Endpoint domain: Mortality/survival
Primary endpoint: survival rates without transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Area Under the Concentration-Time Curve from Time 0 to Infinity (AUC0-Inf) of Nemtabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Nemtabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Terminal Half-life (t1/2) of Nemtabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Autism Diagnostic Observation Scale (ADOS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance of a composite multimodal score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein uptake in g/kg body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Toxicity as measured by number of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Stabilizing of blood sugar levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Delay in reporting side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Cervical cancer screening uptake rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fat Retention Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of non-progression at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute gastrointestinal non-toxicity rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in myocardial performance index (MPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HbA1c trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visit Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine toxicology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of participants achieving 10% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 10-Year Risk of Cardiovascular Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Amplitude of 24-h rhythm of core body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acrophase 24-h rhythm of core body temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of pressure under their feet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5 times sit to stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in range of ankle motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in foot functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in ankle stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Fugl-meyer Assessment Upper Extremity motor functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Index of Erectile Function (IIEF-EF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erection Hardness Scale (EHS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intravaginal Latency Time (IELT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Esteem And Relationship Questionnaire (Sear)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness of detecting nasogastric tube's distal tip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Functional assessment change
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dependency in Activities of Daily Living (ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Pittsburgh Sleep Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: 5-year cumulative live birth rate
Endpoint domain: Mortality/survival
Primary endpoint: incidence of treatment failure
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of days engaged in prehabilitation before surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Heart Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: High-grade neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: insulin-stimulated fluorodeoxyglucose uptake in quadriceps muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PrEP retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Quality of Life Scale on the Minnesota Living with Heart Failure Questionnaire (MLHFQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient Self Confidence on the Self-Care Heart Failure Index (SCHFI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Caregiver Self Confidence on the Caregiver Contribution for Self-Care Heart Failure Index (CC-SCHFI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: B cell response to albumin treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Other immune cell response to albumin treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants without grade 3 or 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Neutralization antibodies titers (anti-RBD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: BOLD response during Monetary Incentive Delay Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MR Imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility and acceptability of treatment monitoring and educational components
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Extent of low anterior resection syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Anxiety levels assessed using STAI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mood assessed using Profile of Mood State (POMS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in serum testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: visual fatigue
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: physique ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini Mental State Exam (MMSE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Severity of the COVID-19 total and individual symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of progression to disease severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myofibrillar fractional synthetic rate change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of microorganisms in trophoblast samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in mean log10 serum hepatitis B surface antigen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects whose serum hepatitis B surface antigen (HBsAg) had turned negative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratio of arrested cavity lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Pharmacokinetic parameters of clofazimine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adequacy of ANC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peri-implant probing pocket depth (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic bone level (RBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunohistochemical expression of EMT-related markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebrovascular reactivity to carbon dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neonatal Neurological insult
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maternal toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Manuel Ability Measure
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: HLA antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Defecation type
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Physical, functional and physiological responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unanticipated events
Endpoint domain: Adverse events/effects
Primary endpoint: Cerebral Vascular Reactivity to Hypercapnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral Blood Flow Response to Hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Protein changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acylated ghrelin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Dietary intake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Liking and wanting for specific foods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Specific sensory desire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total plasma apolipoprotein B concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients participating in buddy support programs
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mean rating of satisfaction with the ABI-motion program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction on HDRS-17
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Randomization acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Response rate to the trial questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportions of participants diagnosed with osteoporosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and joint outcomes
Primary endpoint: End-tidal CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PVT Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carbon dioxide tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pre-test post-test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of capillary HbCO measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Esophageal Eosinophilia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in DPV and LNG concentrations in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in DPV and LNG concentrations in cervicovaginal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the level of fear-avoidance beliefs
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Vaginal Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of the RecoveryFun system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the RecoveryFun system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients identified and treated for sexual dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of patients identified and treated for urinary dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Uncertainty Scale (U-Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fear Extinction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of oral medication administration errors in self-administered patients
Endpoint domain: Adverse events/effects
Primary endpoint: Total number of oral medication administration errors in patients receiving administration by nurses
Endpoint domain: Adverse events/effects
Primary endpoint: proportion completing the exercise intervention
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: proportion of patients completing physical fitness tests
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of participants experiencing aspiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total ocular surface staining (Oxford score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful ventilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity and specificity of [18F]FES PET/CT assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Positive predictive value of [18F]FES PET/CT assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Negative predictive value of [18F]FES PET/CT assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of participants reporting treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Plasma Concentration-Time Curve (AUC∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cranio-vertebral angle (CVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mouth opening angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral movements of the mandible
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes